Related Experiment Video
Updated: Jan 30, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133
1University of Colorado Cancer Center, Aurora, CO.
Abstract:
The treatment landscape of small-cell lung cancer is rapidly evolving. Results of the first-line randomized trial comparing etoposide/carboplatin/placebo with etoposide/carboplatin/atezolizumab (IMpower-133) were recently published, showing a longer progression-free survival and overall survival for patients receiving atezolizumab. These results changed the standard first-line therapy for the first time in several decades. There are 4 additional ongoing randomized trials comparing chemotherapy alone with chemotherapy plus immune checkpoint inhibition as initial treatment. In addition to these major changes in first-line treatment, multiple second or later line options with new agents are likely to change therapeutic standards in these settings. In this article, we discuss the changing treatment landscape following IMpower-133, highlight new second/subsequent line approaches, and discuss the role of biomarkers in patient selection for these treatments.
Related Concept Videos
Lung Capacity
Global Climate Change
Net Change Theorem
Rates of Change
Work Done During Volume Change
Consider a gas confined to a cylinder fitted with a movable piston at one end. If the gas expands from volume V1 to volume V2, it exerts a force on the piston, such that the piston moves by a distance dr.
The work done by the gas on the piston can be expressed as
Le Chatelier's Principle: Changing Temperature
To understand this phenomenon, consider the elementary reaction:

